Whitelab Genomics
AI and computational biology tools for biotech and pharmaceutical teams developing genomic medicines
Highlights
- New on EvolcAdded 2026-10-29
About Whitelab Genomics
WhiteLab Genomics develops AI and computational biology tools to support therapeutic target discovery and molecular design for genomic medicines, including AAV, lentiviral, and lipid nanoparticle therapies. Its ALFRED platform combines curated data, predictive modeling, and computational biology to optimize candidates for safety and efficacy.
The company works with drug developers, manufacturers, and academic centers on tailored R&D solutions, including in-silico design and wet-lab validation through external capabilities. Founded in 2019, it is based in Evry-Courcouronnes, with team hubs in Paris, Boston, and Montreal; it is backed by Y Combinator.
Product: ALFRED, an AI platform and computational biology toolkit for genomic medicine target discovery and therapeutic design.
Jobs at Whitelab Genomics
More biotech & pharma companies
Xenothera
Develops glyco-humanized antibody treatments for patients with a range of therapeutic needsNew on EvolcZymoptiq
Enzyme activity testing products and analytical services for industrial and research customersNew on Evolc4P-Pharma
Clinical-stage biotech developing drug candidates for serious diseases with unmet medical needsNew on EvolcAb Science
Develops pharmaceutical compounds for clinical programs in neurology, inflammatory diseases, oncology and viral diseasesNew on EvolcAbbelight
Super-resolution microscopy platform, sample-prep reagents and analysis software for biology researchers and biotech labsNew on EvolcAbivax
Develops obefazimod and other therapeutics for patients with chronic inflammatory diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- Nuxt
- Vue